SLN
OTC MARKETS · Biotechnology
Silence Therapeutics PLC
$13.97
+0.39 (+2.87%)
Performance
1D
—
1W
-9.46%
1M
+27.93%
3M
+124.24%
6M
+118.97%
1Y
+118.97%
YTD
+118.97%
Open$14.07
Previous Close$13.58
Day High$14.24
Day Low$13.36
52W High$5.99
52W Low$1.06
Volume—
Avg Volume2.8K
Market Cap641.61M
P/E Ratio—
EPS$-0.53
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$9.57
Above
RSI (14)
65.7
Neutral
Key Financials
| FY 2026 | |
|---|---|
| Revenue | 10.49M |
| Net Income | -24,323,307 |
| Profit Margin | -231.4% |
| EBITDA | -24,883,165 |
| Free Cash Flow | — |
| Rev Growth | +315.5% |
| Debt/Equity | 2.02 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |